For Synergy Pharmaceuticals Inc. (SGYP), whose shares are down 11% year-to-date, the worst may be behind it. With Synergy Pharma taking all steps to effectively manage costs while simultaneously investing in strategic initiatives that deliver growth to the Company's top-line, it is worth keeping an eye on this stock.
from RTT - Biotech http://ift.tt/2s6BiFz
via IFTTT
No comments:
Post a Comment